fbpx
Drop Us a Quick Message

    Latest Updates
    s

    Bayer stock surges on report it is open to glyphosate settlement.

    A wave of lawsuits over the flagship herbicide batters Bayer after its mammoth takeover of US seeds and pesticides maker Monsanto. B-Concept Group

    Bayer stock surges on report it is open to glyphosate settlement.

    An $8 billion settlement would be well below estimates from analysts, who predict the legal tangle could end up costing well over 10 billion euros.

    A wave of lawsuits over the flagship herbicide batters Bayer after its mammoth takeover of US seeds and pesticides maker Monsanto for $63 billion last year, based on its active ingredient glyphosate.

    Juries in several lower courts granted plaintiffs significant damages awards, although judges later reduced them vowed to appeal — saying the weight of scientific evidence is against glyphosate causing cancer when used appropriately.

    Plaintiffs’ lawyers have often argued that classed glyphosate as “probably carcinogenic”. The lawyers based this on a 2015 finding by the World Health Organization arm IARC.

    But this was a finding in absolute terms, rather than one related to typical levels of exposure.

    Bayer points to long-term studies of thousands of glyphosate users, which it says show no increased cancer risk.

    AFP / B-Concept Group

    Author

    B-Concept is an Award-Winning Events Agency, Media and Ticket Company in Bangkok, Thailand.

    Post a Comment

    X
    X